Recent Mergers & Acquisitions (M&A) Deals Data in Healthcare
Sabine Hospital and Research Centre
Deal Size: INR 13.0 Billion
Announced Date: Oct 2026
Indira IVF in talks to acquire Sabine in nearly Rs 1,300 crore deal
Zymeworks
Deal Size: $ 929 Million
Announced Date: Sep 2026
Zymeworks Completes Acquisition of Theravance Biopharma
Universal Health Services
Deal Size: $835 Million
Announced Date: Aug 2026
Universal Health Services, Inc. has been active in its acquisition strategy, particularly in the virtual behavioral health sector. The company’s recent acquisition of Talkspace, Inc. is a significant move aimed at expanding its services and improving access to behavioral healthcare. This acquisition is expected to enhance UHS’ outpatient and telehealth behavioral health strategies, diversify its payor mix, and deliver a comprehensive, technology-enabled continuum of care.
Ascension Health
Deal Size: $3.9 Billion
Announced Date: July 2026
A $5 billion wave of M&A has hit the ASC industry, with several major deals reshaping ownership. Notable transactions include Ascension’s $3.9 billion acquisition of AmSurg, which expanded its network of ambulatory surgery centers, and Surgery Partners’ $1.15 billion divestiture of two Idaho hospitals. These moves reflect a trend of consolidation among health systems and physician-owned platforms in the ASC sector.
Abbott Laboratories
Deal Size: $21 Billion
Announced Date: July 2026
Abbott Laboratories (ABT) is due to report second-quarter earnings on July 16 before market open, with analysts expecting the firm to report healthy top- and bottom-line growth.The firm’s earnings are expected to inch up by 1.6% to $1.28 per share, while revenue is expected to rise 12.4% to $12.52B.
Thoreau Group
Deal Size: $12 Billion
Announced Date: June 2026
Matt Holt’s private investment firm Thoreau Group is in advanced discussions to acquire US revenue cycle management company Ensemble Health Partners in a transaction valued at around $12bn, according to a report by Bloomberg citing unnamed people familiar with the matter.
Merck
Deal Size: $6.7 Billion
Announced Date: May 2026
Merck has completed its $6.7 billion acquisition of Terns Pharmaceuticals, adding the investigational CML therapy TERN-701 to its oncology and hematology pipeline.
How can you benefit from the Intellizence Mergers & Acquisitions (M&A) Dataset?
Identify Prospective Customers:
Intellizence M&A dataset provides valuable insights into healthcare companies that have recently undergone Mergers or Acquisitions. This information allows sales teams to identify potential healthcare customers who may need new products or services, are experiencing organizational changes, or are looking to expand their operations.
Expand Cross-Selling and Upselling Opportunities:
Intellizence M&A dataset enables sales, account management, and customer success teams to identify cross-selling and upselling opportunities within their existing customer base in healthcare. By analyzing the acquisitions or divestments in their healthcare customers, they can uncover areas where additional products or services may be required and ultimately drive increased revenue from existing accounts.
Investment and Trading:
The Intellizence M&A dataset serves as a goldmine for investors and financial analysts. By analyzing historical M&A transactions in the healthcare industry, investment teams can identify trends and industry dynamics, assess market sentiment, and make better investment strategies.
Corporate Development and Strategy:
By analyzing the Intellizence M&A dataset, corporate development and strategy professionals can better understand consolidation, emerging market trends, and competitive dynamics in the healthcare sector. This knowledge helps evaluate market gaps, identify strategic alliances, and devise plans to expand market share and diversify offerings.
Competitive Intelligence:
Intellizence M&A dataset offers timely intelligence about corporate mergers & acquisitions, divestments, and spinoffs in healthcare. By tracking these events, sales and competitive intelligence teams can gain insights into their competitors’ strategies, identify potential vulnerabilities, and differentiate themselves in the market.
Why Subscribe to Intellizence Mergers & Acquisitions (M&A) Dataset?
AI-Powered Platform:
The Intellizence company intelligence platform is powered by cutting-edge Natural Language Processing and Machine Learning technologies that curate M&A data from multiple external sources. Every record is human-audited for data integrity.
Delivered in Near Real-time:
Intellizence monitors thousands of sources in real-time for any latest M&A announcements from various unstructured external sources and delivers merger & acquisition data in a structured format.
Comprehensive Coverage:
Intellizence curates the data from news sources, including <industry name> focused news sites, press wires, and regulatory filings to ensure comprehensive coverage. The intellizence M&A dataset covers data from healthcare and all other emerging and established industries.
Multiple Delivery Channels:
The M&A news is delivered through multiple channels – Web Platform, Email Alerts, Slack, CRM, and ChatGPT Plugin. We offer API to power your applications and models with real-time merger & acquisition news and data.
One-Stop Data Provider for Company Signals:
In addition to Merger & Acquisition News & Data, Intellizence offers curated news on 80+ company signals and structured datasets – Startup Funding, Mergers & Acquisitions, Business Expansion, Major Hiring, CXO Appointments & Changes, and Data & Security Breaches.
More about Intellizence M&A Dataset
Subscribe to Intellizence to get the latest intelligence about healthcare companies for sales intelligence, competitive intelligence, customer intelligence, market intelligence, and risk intelligence activities.
Latest Mergers & Acquisitions (M&A) Data – Explore Other Industries